• Zhaoke Ophthalmology’s presbyopia eye drop YUVEZZI won Macau drug regulator clearance on July 13 for presbyopia treatment.
• Product is a once-daily, preservative-free fixed-dose combo of 2.75% carbachol, 0.1% brimonidine tartrate.
• Zhaoke is seeking inclusion in the “Hong Kong-Macau Medicine and Device Connect” scheme to speed access in the Greater Bay Area.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhaoke Ophthalmology Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260720-12249212), on July 20, 2026, and is solely responsible for the information contained therein.